{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:29:45Z","timestamp":1777631385597,"version":"3.51.4"},"reference-count":43,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Although exhaustive efforts to prevent and treat tuberculosis (TB) have\nbeen made, the problem still continues due to multi-drug-resistant (MDR) and extensively drugresistant\nTB (XDR-TB). It clearly highlights the urgent need to develop novel \u201cdruggable\u201d molecules\nfor the co-infection treatment and strains of MDR-TB and XDR-TB.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this approach, a hybrid molecule was created by merging two or more pharmacophores.\nThe active site of targets may be addressed by each of the pharmacophores and proffers the opportunity\nfor selectivity. In addition, it also reduces undesirable side effects and drug-resistance.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> In this study, a novel quinazolinone analog was designed and synthesized by substituting\nthiourea nucleus and phenyl ring at N-3 and C-2 position of quinazoline ring, respectively. All title\ncompounds were tested for antitubercular activity by in vitro M. tuberculosis and anti-human immunodeficiency\nvirus (HIV) activity by MT-4 cell assay method. The agar dilution method was\nused to test the antibacterial potency of entire prepared derivatives against various strains of grampositive\nand gram-negative microorganisms.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The title compounds, 1-(substituted)-2-methyl-3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)\nisothioureas (QTS1 \u2013 QTS15) were synthesized by the reaction between key intermediate 3-amino-\n2-phenylquinazolin-4(3H)-one with various alkyl\/aryl isothiocyanates followed by methylation with\ndimethyl sulphate. Among the series, compound 1-(3-chlorophenyl)-2-methyl-3-(4-oxo-2-phenyl\nquinazolin- 3(4H)-yl) isothioureas (QTS14) showed the highest potency against B. subtilis, K.\npneumonia and S. aureus at 1.6 \u03bcg\/mL. The compound QTS14 exhibited the most potent antitubercular\nactivity at the MIC of 0.78 \u03bcg\/mL and anti-HIV activity at 0.97 \u03bcg\/mL against HIV1 and\nHIV2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results obtained from this study confirm that the synthesized and biologically\nevaluated quinazolines showed promising antimicrobial, antitubercular and anti-HIV activities. The\nnew scaffolds proffer a plausible lead for further development and optimization of novel antitubercular\nand anti-HIV drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406416666200817153033","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T08:08:42Z","timestamp":1597738122000},"page":"352-368","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas"],"prefix":"10.2174","volume":"17","author":[{"given":"Mohaideen Thasthagir","family":"Sulthana","sequence":"first","affiliation":[{"name":"Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy - 502 294, Gr. Hyderabad,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-7912","authenticated-orcid":true,"given":"Veerachamy","family":"Alagarsamy","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy - 502 294, Gr. Hyderabad,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan","family":"Chitra","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, 600 116,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","year":"2018","unstructured":"World health organization, Global tuberculosis report 2018 World health organization: Geneva Switzerland 2018","journal-title":"Switzerland"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"27048","DOI":"10.3402\/gha.v8.27048","volume":"8","author":"Balcha T.T.","year":"2015","unstructured":"Balcha T.T.; Skogmar S.; Stureg\u00e5rd E.; Bj\u00f6rkman P.; Winqvist N.; Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding. Glob Health Action 2015,8,27048-27049","journal-title":"Glob Health Action"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1473-3099(09)70043-X","volume":"9","author":"Reid M.J.","year":"2009","unstructured":"Reid M.J.; Shah N.S.; Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009,9(3),173-184","journal-title":"Lancet Infect Dis"},{"key":"ref=4","unstructured":"World Health Organization Tuberculosis https:\/\/www.who.int\/tb\/en\/"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14787210.2020.1760845","volume":"20","author":"Rodrigues L.","year":"2020","unstructured":"Rodrigues L.; Cravo P.; Viveiros M.; Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs. Expert Rev Anti Infect Ther 2020,20,1-17","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12879-020-05031-5","volume":"20","author":"Chisompola N.K.","year":"2020","unstructured":"Chisompola N.K.; Streicher E.M.; Muchemwa C.M.K.; Warren R.M.; Sampson S.L.; Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review. BMC Infect Dis 2020,20(1),344","journal-title":"BMC Infect Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ejmech.2018.03.076","volume":"151","author":"Alagarsamy V.","year":"2018","unstructured":"Alagarsamy V.; Chitra K.; Saravanan G.; Solomon V.R.; Sulthana M.T.; Narendhar B.; An overview of quinazolines: Pharmacological significance and recent developments. Eur J Med Chem 2018,151,628-685","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13543776.2018.1432596","volume":"28","author":"Hameed A.","year":"2018","unstructured":"Hameed A.; Al-Rashida M.; Uroos M.; Ali S.A.; Ishtiaq M.; Khan K.M.; Quinazoline and quinazolinone as important medicinal scaffolds: A comparative patent review (2011-2016). Expert Opin Ther Pat 2018,28,281-297","journal-title":"Expert Opin Ther Pat"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.ejmech.2010.01.028","volume":"45","author":"Pavan F.R.","year":"2010","unstructured":"Pavan F.R.; da S Maia, P.I.; Leite, S.R.; Deflon, V.M.; Batista, A.A.; Sato, D.N.; Franzblau, S.G.; Leite, C.Q.; Leite, C.Q. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide\/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur J Med Chem 2010,45(5),1898-1905","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"8976","DOI":"10.1016\/j.bmc.2008.08.050","volume":"16","author":"G\u00fczel O.","year":"2008","unstructured":"G\u00fczel O.; Karali N.; Salman A.; Synthesis and antituberculosis activity of 5-methyl\/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives. Bioorg Med Chem 2008,16(19),8976-8987","journal-title":"Bioorg Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1016\/j.bmc.2007.05.063","volume":"15","author":"Karali N.","year":"2007","unstructured":"Karali N.; G\u00fcrsoy A.; Kandemirli F.; Shvets N.; Kaynak F.B.; Ozbey S.; Kovalishyn V.; Dimoglo A.; Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg Med Chem 2007,15(17),5888-5904","journal-title":"Bioorg Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1021\/jm060339h","volume":"49","author":"Sriram D.","year":"2006","unstructured":"Sriram D.; Yogeeswari P.; Thirumurugan R.; Pavana R.K.; Discovery of new antitubercular oxazolyl thiosemicarbazones. J Med Chem 2006,49(12),3448-3450","journal-title":"J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bmcl.2008.12.088","volume":"19","author":"Sriram D.","year":"2009","unstructured":"Sriram D.; Yogeeswari P.; Dhakla P.; Senthilkumar P.; Banerjee D.; Manjashetty T.H.; 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species. Bioorg Med Chem Lett 2009,19(4),1152-1154","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=14","first-page":"824","volume":"46","author":"Saripinar E.","year":"1996","unstructured":"Saripinar E.; G\u00fczel Y.; Patat S.; Yildirim I.; Ak\u00e7amur Y.; Dimoglo A.S.; Electron-topological investigation of structure-antitubercular activity relationship of thiosemicarbazone derivatives. Arzneimittelforschung 1996,46(8),824-828","journal-title":"Arzneimittelforschung"},{"key":"ref=15","first-page":"121","volume":"56","author":"Milczarska B.","year":"1999","unstructured":"Milczarska B.; Foks H.; Soko\u0142owska J.; Janowiec M.; Zwolska Z.; Andrzejczyk Z.; Studies on pyrazine derivatives. XXXIII. Synthesis and tuberculostatic activity of 1-[1-(2-pyrazinyl)-ethyl]-4-N-substituted thiosemicarbazide derivatives. Acta Pol Pharm 1999,56(2),121-126","journal-title":"Acta Pol Pharm"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ejmech.2007.07.001","volume":"43","author":"Turan-Zitouni G.","year":"2008","unstructured":"Turan-Zitouni G.; Ozdemir A.; Kaplancikli Z.A.; Benkli K.; Chevallet P.; Akalin G.; Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives. Eur J Med Chem 2008,43(5),981-985","journal-title":"Eur J Med Chem"},{"key":"ref=17","first-page":"27","volume":"55","author":"Pandeya S.N.","year":"2005","unstructured":"Pandeya S.N.; Smitha S.; Jyoti M.; Sridhar S.K.; Biological activities of isatin and its derivatives. Acta Pharm 2005,55(1),27-46","journal-title":"Acta Pharm"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1039\/b316419p","volume":"21","author":"Webb M.E.","year":"2004","unstructured":"Webb M.E.; Smith A.G.; Abell C.; Biosynthesis of pantothenate. Nat Prod Rep 2004,21(6),695-721","journal-title":"Nat Prod Rep"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.coph.2006.06.004","volume":"6","author":"Mdluli K.","year":"2006","unstructured":"Mdluli K.; Spigelman M.; Novel targets for tuberculosis drug discovery. Curr Opin Pharmacol 2006,6(5),459-467","journal-title":"Curr Opin Pharmacol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"22902","DOI":"10.1016\/S0021-9258(18)50032-6","volume":"267","author":"Grassl S.M.","year":"1992","unstructured":"Grassl S.M.; Human placental brush-border membrane Na(+)-pantothenate cotransport. J Biol Chem 1992,267(32),22902-22906","journal-title":"J Biol Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1128\/JB.164.1.136-142.1985","volume":"164","author":"Vallari D.S.","year":"1985","unstructured":"Vallari D.S.; Rock C.O.; Isolation and characterization of Escherichia coli pantothenate permease (panF) mutants. J Bacteriol 1985,164(1),136-142","journal-title":"J Bacteriol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ar7000843","volume":"41","author":"Meunier B.","year":"2008","unstructured":"Meunier B.; Hybrid molecules with a dual mode of action: dream or reality? Acc Chem Res 2008,41(1),69-77","journal-title":"Acc Chem Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1021\/acs.jafc.9b07449","volume":"68","author":"Zhang Y.Y.","year":"2020","unstructured":"Zhang Y.Y.; Gao S.; Liu Y.X.; Wang C.; Jiang W.; Zhao L.X.; Fu Y.; Ye F.; Design, Synthesis, and Biological Activity of Novel Diazabicyclo Derivatives as Safeners. J Agric Food Chem 2020,68(11),3403-3414","journal-title":"J Agric Food Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.bmcl.2018.12.061","volume":"29","author":"Fu Y.","year":"2019","unstructured":"Fu Y.; Zhang D.; Kang T.; Guo Y.Y.; Chen W.G.; Gao S.; Ye F.; Fragment splicing-based design, synthesis and safener activity of novel substituted phenyl oxazole derivatives. Bioorg Med Chem Lett 2019,29(4),570-576","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1747-0285.2009.00794.x","volume":"73","author":"Alagarsamy V.","year":"2009","unstructured":"Alagarsamy V.; Raja Solomon V.; Sheorey R.V.; Jayakumar R.; 3-(3-ethylphenyl)-2-substituted hydrazino-3H-quinazolin-4-one derivatives: new class of analgesic and anti-inflammatory agents. Chem Biol Drug Des 2009,73(4),471-479","journal-title":"Chem Biol Drug Des"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.4067\/S0717-97072016000200002","volume":"61","author":"Alagarsamy V.","year":"2016","unstructured":"Alagarsamy V.; Appani R.; Sulthana M.T.; Narendar B.; Solomon V.R.; Design, synthesis and antimicrobial activities of 1-(4-oxo-3-(4-fluorophenyl)-3H-quinazolin-2-yl)-4-(substituted) thiosemicarbazide derivatives. J Chil Chem Soc 2016,61,2856-2860","journal-title":"J Chil Chem Soc"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M.","year":"2000","unstructured":"Kanehisa M.; Goto S.; KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000,28(1),27-30","journal-title":"Nucleic Acids Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ddr.21460","volume":"79","author":"Saravanan G.","year":"2018","unstructured":"Saravanan G.; Panneerselvam T.; Alagarsamy V.; Kunjiappan S.; Parasuraman P.; Murugan I.; Dinesh Kumar P.; Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives. Drug Dev Res 2018,79(6),260-274","journal-title":"Drug Dev Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-0043-120198","volume":"68","author":"Saravanan G.","year":"2018","unstructured":"Saravanan G.; Selvam T.P.; Alagarsamy V.; Kunjiappan S.; Joshi S.D.; Indhumathy M.; Kumar P.D.; Graph theoretical analysis, in silico modeling, synthesis, anti-microbial and anti-TB evaluation of novel quinoxaline derivatives. Drug Res (Stuttg) 2018,68(5),250-262","journal-title":"Drug Res (Stuttg)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ddr.21511","volume":"80","author":"Saravanan G.","year":"2019","unstructured":"Saravanan G.; Panneerselvam T.; Kunjiappan S.; Parasuraman P.; Alagarsamy V.; Udayakumar P.; Soundararajan M.; Joshi S.D.; Ramalingam S.; Ammunje D.N.; Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2-(methyl\/phenyl)-3-(4-(5-substituted-1,3,4-oxadiazol-2-yl) phenyl) quinazolin-4(3H)-ones as NMDA receptor inhibitor. Drug Dev Res 2019,80(3),368-385","journal-title":"Drug Dev Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molstruc.2012.05.059","volume":"1026","author":"\u0130nkaya E.","year":"2012","unstructured":"\u0130nkaya E.; Din\u00e7er M.; Ekici \u00d6.; Cukurovali A.N.; \u2032-(2-methoxy-benzylidene)-N-[4-(3-methyl-3-phenyl-cyclobutyl)-thiazol-2-yl]-chloro-acetic hydrazide: X-ray structure, spectroscopic characterization and DFT studies. J Mol Struct 2012,1026,117-126","journal-title":"J Mol Struct"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.molstruc.2012.05.002","volume":"1022","author":"G\u00fcntepe F.","year":"2012","unstructured":"G\u00fcntepe F.; Sara\u00e7o\u011flu H.; \u00c7al\u0131\u015fkan N.; Y\u00fcksektepe \u00c7.; Cukurovali A.; Synthesis, molecular and crystal structure analysis of 2-bromo-4-chloro-6-{[4-(3-methyl-3-phenyl-cyclobutyl)-thiazol-2-yl]-hydrazonomethyl}-phenol by experimental methods and theoretical calculations. J Mol Struct 2012,1022,204-210","journal-title":"J Mol Struct"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/bioinformatics\/btq584","volume":"26","author":"Rydberg P.","year":"2010","unstructured":"Rydberg P.; Gloriam D.E.; Olsen L.; The SMARTCyp cytochrome P450 metabolism prediction server. Bioinformatics 2010,26(23),2988-2989","journal-title":"Bioinformatics"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1016\/j.bmc.2005.05.063","volume":"13","author":"Sriram D.","year":"2005","unstructured":"Sriram D.; Yogeeswari P.; Basha J.S.; Radha D.R.; Nagaraja V.; Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. Bioorg Med Chem 2005,13(20),5774-5778","journal-title":"Bioorg Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1016\/j.bmcl.2011.10.048","volume":"21","author":"Shanmugavelan P.","year":"2011","unstructured":"Shanmugavelan P.; Nagarajan S.; Sathishkumar M.; Ponnuswamy A.; Yogeeswari P.; Sriram D.; Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem Lett 2011,21(24),7273-7276","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0014-827X(00)00100-2","volume":"55","author":"Kunes J.","year":"2000","unstructured":"Kunes J.; Bazant J.; Pour M.; Waisser K.; Slos\u00e1rek M.; Janota J.; Quinazoline derivatives with antitubercular activity. Farmaco 2000,55(11-12),725-729","journal-title":"Farmaco"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0166-0934(87)90002-4","volume":"16","author":"Pauwels R.","year":"1987","unstructured":"Pauwels R.; De Clercq E.; Desmyter J.; Balzarini P.; Goubabu P.; Herdesijin P.; Vanderhaughe H.; Vandeputle M.J.; Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. Virol Methods 1987,16,171-185","journal-title":"Virol Methods"},{"key":"ref=38","author":"Barry A.","year":"1991 p. 1","unstructured":"Barry A.; Antibiotics in Laboratory Medicine. William and Wilkins, 5th ed; Baltimore, MD 1991 p. 1","journal-title":"5th ed; Baltimore, MD"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0014-827X(99)00075-0","volume":"54","author":"Pandeya S.N.","year":"1999","unstructured":"Pandeya S.N.; Sriram D.; Nath G.; De Clercq E.; Synthesis and antimicrobial activity of Schiff and Mannich bases of isatin and its derivatives with pyrimidine. Farmaco 1999,54(9),624-628","journal-title":"Farmaco"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00726-014-1782-3","volume":"46","author":"Saghyan A.S.","year":"2014","unstructured":"Saghyan A.S.; Simonyan H.M.; Petrosyan S.G.; Geolchanyan A.V.; Roviello G.N.; Musumeci D.; Roviello V.; Thiophenyl-substituted triazolyl-thione L-alanine: asymmetric synthesis, aggregation and biological properties. Amino Acids 2014,46(10),2325-2332","journal-title":"Amino Acids"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2019.117884","volume":"229","author":"Fik-Jask\u00f3\u0142ka M.A.","year":"2020","unstructured":"Fik-Jask\u00f3\u0142ka M.A.; Mkrtchyan A.F.; Saghyan A.S.; Palumbo R.; Belter A.; Hayriyan L.A.; Simonyan H.; Roviello V.; Roviello G.N.; Spectroscopic and SEM evidences for G4-DNA binding by a synthetic alkyne-containing amino acid with anticancer activity. Spectrochim Acta A Mol Biomol Spectrosc 2020,229","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=42","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2018-0473","author":"Vicidomini C.","unstructured":"Vicidomini C.; Cioffi F.; Broersen K.; Roviello V.; Riccardi C.; Montesarchio D.; Capasso D.; Di Gaetano S.; Musumeci D.; Roviello G.N.; Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound. Future Med Chem, 2019, Online ahead of print","journal-title":"Future Med Chem, 2019, Online ahead of print"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"8089","DOI":"10.1021\/jm1009605","volume":"53","author":"Garofalo A.","year":"2010","unstructured":"Garofalo A.; Goossens L.; Baldeyrou B.; Lemoine A.; Ravez S.; Six P.; David-Cordonnier M.H.; Bonte J.P.; Depreux P.; Lansiaux A.; Goossens J.F.; Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives. J Med Chem 2010,53(22),8089-8103","journal-title":"J Med Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406416666200817153033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184927\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406416666200817153033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T08:12:22Z","timestamp":1660464742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184927\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406416666200817153033","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}